Tagged with EG

Pharma Prof. Walter Ricciardi has just been appointed as the new president for the Italian National Institute of Health (ISS). He explains his priorities since taking office, the crucial role the ISS plays in the NHS and his vision for the future of the Italian National Healthcare System. Prof. Ricciardi, can…

Pharma Bert de Jong, General Manager Benelux at Genzyme, discusses the solutions Genzyme is offering to patients suffering from rare diseases and MS in the Benelux and how these treatments add value overall to society, as well as the company’s changing role in the Sanofi organization with the addition of the oncology and…

Pharma Roche Netherlands General Manager Bart Vanhauwere explains how the company has managed to foster growth at the Dutch affiliate thanks to its long-term strategic vision and the collaborative approach it has taken with stakeholders, as well as the affiliate’s role as a pioneer in introducing innovative pricing models like pay…

pharma   The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International companies must however adapt their strategies to suit the Thai market; as must domestic concerns. With an estimated value of USD 4.5 billion, Thailand is Southeast Asia’s second largest…

Pharma Europe’s longest-standing Minister of Health, Edith Schippers, provides insight into the local healthcare system and continued efforts to improve quality of life for Dutch citizens, as well as revealing the main policy priorities of the Ministry for the Dutch presidency of the European Union in the first semester of 2016.…

Pharma Pharmed Healthcare is the only Egyptian company to hold a License from the innovator to produce generic sofosbuvir, but faces competition from at least ten different companies in the market. Given your experience in trying to combat the hepatitis C virus (HCV), which is an epidemic in Egypt, what are some…

Pharma The Managing Director of MSD Egypt highlights MSD’s unique incentives to further collaborate with the Egyptian medical community and explains how market peculiarities shape product launches in developing countries like Egypt. As newly appointed Managing Director for MSD Egypt, could you please outline your objectives and ambitions in the Egyptian…

Pharma Dr. Mohamed El Ganayni, Managing Director at UniPharma discusses the challenges in standing out among a crowd of Egyptian pharmaceutical manufacturers, elaborates on his ambitions to become a Top 30 local pharma player and gives an insight into his strategy to enter the European market by 2020. To begin, can…

Pharma Empty markets, where strong and growing demand exists but local supply does not, offer the most potential to prospective investors in Egypt, according to Delta Pharma Bio general manager Mohamed Aldeeb. Aldeeb goes on to explain that such markets include oncology, biosimilars, and baby formula. What makes Egypt ‘the land of…

Pharma Deputy Minister of Health for Pharmaceutical Affairs Tarek Salman discusses how pharmaceutical regulation in Egypt is taking a leap forward, with the introduction of new legislation with parallel registration process that will bring approval timelines under 21 months, and the imminent establishment of the Egyptian Drug Authority, which will merge…

Pharma In Egypt’s diverse marketplace, Novo Nordisk is bringing care to patients across the country with a range of products ranging from affordable established insulin to their most recent generation of innovative products. At the same time, they are investing in localizing production of insulin in Egypt and encouraging best practices in diabetes…

Pharma Giulio Volpe, Managing Director of Lundbeck’s Italian API’s production plant, discusses what is leading multinational companies to relocate their production to Italy, the value the Italian plant can offer the Lundbeck group and the future of API production in Italy. Could you start off with a brief overview of the…